[pending] SUCRALFATE (SUCRALFATE)
Pending LLM rewrite. Source: FDA_DRUG D-0027-2026.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.
The recalled product
- Product
- SUCRALFATE (SUCRALFATE)
- Brand
- SUCRALFATE
- Manufacturer
- Amerisource Health Services LLC
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 1017392
- Exp. Date 01/31/2026
- 1017415
- Exp. Date 12/31/2025.
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · SUCRALFATE
- SevereFDA Recalls Sucralfate Oral Suspension Due to Bacillus Cereus Contamination
FDA (Drugs) · 2023-10-25
- HighPrescription Drug Sucralfate Suspension Recalled for Out-of-Specification Potency
FDA (Drugs) · 2023-09-20
Same category
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- ModerateCAREone Earwax Removal Drops Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22